M. Bramnert

发表

Effects of morning cortisol replacement on glucose and lipid metabolism in GH-treated subjects.

E. Laurila, L. Groop, M. Segerlantz, 2004, European journal of endocrinology.

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.

E. Laurila, L. Groop, M. Segerlantz, 2003, The Journal of clinical endocrinology and metabolism.

Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.

E. Laurila, L. Groop, M. Segerlantz, 2003, European journal of endocrinology.

Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.

E. Laurila, L. Groop, M. Segerlantz, 2001, The Journal of clinical endocrinology and metabolism.

The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency

M. Thorén, M. Bramnert, T. Elgzyri, 2004, Clinical endocrinology.

Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function.

M. Thorén, G. Johannsson, M. Bramnert, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy

J. Svensson, L. Rylander, M. Thorén, 2013, Psychoneuroendocrinology.

The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.

M. Thorén, B. Bengtsson, L. Carlsson, 1996, The Journal of clinical endocrinology and metabolism.

Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue.

C. Ling, P. Kelly, M. Bohlooly-y, 2005, Biochemical and biophysical research communications.

Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.

M. Thorén, B. Bengtsson, T. Rosén, 1995, European journal of endocrinology.

The Effect of Captopril on Urinary Kinins and Urinary Kallikrein Activity in Essential Hypertension

M. Bramnert, U. Hulthén, B. Hökfelt, 1981 .

Influence of the Opioid System on Sympathetic Activity and the Renin-Aldosterone System in Healthy Males

M. Bramnert, B. Hökfelt, 1988 .

Early postoperative growth hormone levels: high predictive value for long‐term outcome after surgery for acromegaly

C. Nordström, M. Bramnert, S. Valdemarsson, 2000, Journal of internal medicine.

Fracture Incidence in GH‐Deficient Patients on Complete Hormone Replacement Including GH

J. Svensson, L. Hagmar, L. Rylander, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Increased arterial and venous plasma noradrenaline levels in patients with primary hypothyroidism during hypothyroid as compared to euthyroid state

M. Bramnert, P. Manhem, H. Lecerof, 1992, Journal of endocrinological investigation.

The effect of naloxone on blood pressure, heart rate, plasma catecholamines, renin activity and aldosterone following exercise in healthy males

M. Bramnert, 1988, Regulatory Peptides.

Effect of Low Dosage of Naloxone on Clonidine- Induced Changes in Blood Pressure, Catecholamines, Renin, and Aldosterone in Essential Hypertension

M. Bramnert, B. Hökfelt, 1988 .

Failure of naloxone to reduce the clonidine induced reduction of blood pressure and plasma noradrenaline in patients with essential hypertension.

M. Bramnert, B. Hökfelt, 1983, Acta physiologica Scandinavica.

The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients

M. Bramnert, P. Manhem, U. Hulthén, 1981, European journal of clinical investigation.

Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.

E. Laurila, L. Groop, M. Segerlantz, 2001, The Journal of clinical endocrinology and metabolism.

Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.

B. Bengtsson, M. Bramnert, C. Wüster, 2002, European journal of endocrinology.

The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with Type 1 (insulin-dependent) diabetes mellitus

G. Sundkvist, M. Bramnert, P. Manhem, 1990, Diabetologia.

Only a temporary increase of the amount of body protein during long-term treatment with growth-hormone (GH) of adults with GH-deficiency (GHD).

M. Bramnert, P. Manhem, S. Mattsson, 1998, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

The influence of naloxone on exercise-induced increase in plasma pituitary hormones and the subjectively experienced level of exhaustion in healthy males.

M. Bramnert, B. Hökfelt, 1987, Acta endocrinologica.

Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotropin

R. Ekman, J. Thorell, M. Bramnert, 1982, Regulatory Peptides.

Normal visual fields as assessed by computerized static threshold perimetry in patients with untreated primary hypothyroidism.

I. Redlund‐Johnell, M. Bramnert, P. Manhem, 1989, Acta endocrinologica.

Bilateral isolated adrenal coccidioidomycosis

M. Bramnert, L. Klingspor, B. Castor, 1996, Journal of internal medicine.

Early postoperative basal serum GH level and the GH response to TRH in relation to the long‐term outcome of surgical treatment for acromegaly: a report on 39 patients

M. Bramnert, S. Valdemarsson, P. Hedner, 1991, Journal of internal medicine.

Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.

M. Bramnert, B. Hökfelt, 1984, The Journal of clinical endocrinology and metabolism.

Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.

S. Mohan, M. Thorén, M. Bramnert, 2000, The Journal of clinical endocrinology and metabolism.

Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.

B. Norrving, J. Svensson, L. Hagmar, 2007, The Journal of clinical endocrinology and metabolism.

Impaired responses of plasma catecholamines to exercise in diabetic patients with abnormal heart rate reactions to tilt.

G. Sundkvist, M. Bramnert, P. Manhem, 1989, Clinical physiology.

Effect of 6 months of GH treatment on myosin heavy chain composition in GH-deficient patients.

L. Groop, E. Richter, M. Bramnert, 1999, European journal of endocrinology.

Decreased blood pressure response to infused noradrenaline in normotensive as compared to hypertensive patients with primary hypothyroidism

M. Bramnert, P. Manhem, H. Lecerof, 1994, Clinical endocrinology.

Insulin Sensitivity in Adults with Growth Hormone Deficiency and Effect of Growth Hormone Treatment

L. Groop, M. Bramnert, Mikael Segerlantz, 2006, Hormone Research in Paediatrics.

Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction.

G. Sundkvist, M. Bramnert, P. Manhem, 1992, Diabetes research and clinical practice.